INMB Stock Analysis: Buy, Sell, or Hold?
INMB - INmune Bio Inc. Common stock
$1.55
-0.03 (-1.90%)
▼
5d:
-13.89%
30d:
+0.65%
90d:
-15.3%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Mar 26, 2026
Smart Money Accumulation
INMB is down 13.9% this week, but smart money is accumulating calls. Top strike: $2 2026-03-20 with 1,266 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When INMB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: INMB is down 13.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: INMB is down 13.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: INMB is currently trading at $1.55, which is considered slightly low relative to its 30-day fair value range of $1.52 to $1.67.
Technical Outlook: Technically, INMB is in a strong downtrend. Immediate support is located at $1.47, while resistance sits at $1.80.
Market Sentiment: INMB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.33 (+308.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INMB is in a strong downtrend. Immediate support is located at $1.47, while resistance sits at $1.80.
Market Sentiment: INMB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.33 (+308.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.52 -
$1.67
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 308.6% below Wall St target ($6.33)
- WARNING: Recommendation downgraded due to -13.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.52 -
$1.67
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.19
(12.4%)
Support & Resistance Levels
Support Level
$1.47
Resistance Level
$1.80
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.86
Wall Street Target
$6.33
(+308.6%)
Revenue Growth (YoY)
257.1%
Last updated: February 04, 2026 9:13 AM ET
Data refreshes hourly during market hours. Next update: 10:13 AM
Data refreshes hourly during market hours. Next update: 10:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 59 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 62 BUY |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$7 | 62 BUY |
